These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Accumulation and persistence of aminoglycosides in the renal parenchyma]. Rudhardt M; Blanchard P; Fabre J Nouv Presse Med; 1978 Nov; 7(42):3819-23. PubMed ID: 714684 [No Abstract] [Full Text] [Related]
15. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. Glauser MP; Lyons JM; Braude AI J Clin Invest; 1978 Feb; 61(2):403-7. PubMed ID: 621280 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria. Zorov DB Kidney Int; 2010 May; 77(10):841-3. PubMed ID: 20431573 [TBL] [Abstract][Full Text] [Related]
17. Habekacin: nephrotoxicity, pharmacokinetics and prophylactic efficacy in rats. Stewens J; Marre R; Engelbart K; Schulz E; Sack K Arzneimittelforschung; 1985; 35(9):1440-6. PubMed ID: 3910052 [TBL] [Abstract][Full Text] [Related]
18. [Aminoglycosides in pediatrics]. Truckenbrodt H Adv Clin Pharmacol; 1978; 15():141-8. PubMed ID: 676873 [No Abstract] [Full Text] [Related]
19. Use of aminoglycosides in the neonate. Riff L; Schauf V Semin Perinatol; 1982 Apr; 6(2):155-65. PubMed ID: 7048536 [No Abstract] [Full Text] [Related]
20. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)]. Rudzit EA; Lisitsa LI Farmakol Toksikol; 1971; 34(2):246-50. PubMed ID: 4998195 [No Abstract] [Full Text] [Related] [Next] [New Search]